Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea · Delayed Price · Currency is KRW 8,030.00
0.00 (0.00%)
Nov 4, 2026, 3:30 PM KST
Daewon Pharmaceutical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Daewon Pharmaceutical stock has a consensus rating of "Strong Buy" and an average price target of ₩13,000. The average 1-year stock price forecast is 61.89% higher than the current stock price, while the lowest is ₩11,000 (+36.99%) and the highest is ₩15,000 (+86.80%).
Price Target: ₩13,000 (+61.89%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Daewon Pharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | May '25 | Nov '25 | Apr '26 | May '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
628.05B
from 605.43B
Increased by 3.74%
Revenue Next Year
666.63B
from 628.05B
Increased by 6.14%
EPS This Year
249.00
from -65.00
EPS Next Year
1.14K
from 249.00
Increased by 359.57%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.